MX342986B - Formulaciones para el tratamiento de las afecciones de las vias aereas superiores. - Google Patents

Formulaciones para el tratamiento de las afecciones de las vias aereas superiores.

Info

Publication number
MX342986B
MX342986B MX2013004008A MX2013004008A MX342986B MX 342986 B MX342986 B MX 342986B MX 2013004008 A MX2013004008 A MX 2013004008A MX 2013004008 A MX2013004008 A MX 2013004008A MX 342986 B MX342986 B MX 342986B
Authority
MX
Mexico
Prior art keywords
treatment
formulations
disorders
respiratory tract
upper respiratory
Prior art date
Application number
MX2013004008A
Other languages
English (en)
Other versions
MX2013004008A (es
Inventor
Paolo Morazzoni
Ezio Bombardelli
Massimo Ronchi
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of MX2013004008A publication Critical patent/MX2013004008A/es
Publication of MX342986B publication Critical patent/MX342986B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La presente invención se refiere a formulaciones que contienen extractos de Vaccinium myrtilus o de otras especies ricas en antocianósidos, de Punica granatum, de Echinacea, y eventualmente de Krameria triandra; estas formulaciones son útiles en el tratamiento de afecciones de la boca y sus anexos, de la garganta y del aparato respiratorio y en el tratamiento de la gripe; de manera particular, las combinaciones de la presente invención incorporadas a vehiculos apropiados son particularmente útiles en las infecciones bacterianas y virales de la primera infancia.
MX2013004008A 2010-10-11 2011-10-05 Formulaciones para el tratamiento de las afecciones de las vias aereas superiores. MX342986B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A001852A IT1402018B1 (it) 2010-10-11 2010-10-11 Formulazioni per il trattamento delle affezioni delle prime vie respiratorie.
PCT/EP2011/067357 WO2012049045A1 (en) 2010-10-11 2011-10-05 Formulations for the treatment of disorders of the upper respiratory tract

Publications (2)

Publication Number Publication Date
MX2013004008A MX2013004008A (es) 2013-04-24
MX342986B true MX342986B (es) 2016-10-19

Family

ID=43737984

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004008A MX342986B (es) 2010-10-11 2011-10-05 Formulaciones para el tratamiento de las afecciones de las vias aereas superiores.

Country Status (21)

Country Link
US (1) US9168276B2 (es)
EP (1) EP2627345B1 (es)
JP (2) JP6250397B2 (es)
KR (1) KR101870979B1 (es)
CN (1) CN103189065B (es)
AR (1) AR083366A1 (es)
AU (1) AU2011315708B2 (es)
BR (1) BR112013008771B1 (es)
CA (1) CA2814312C (es)
DK (1) DK2627345T3 (es)
ES (1) ES2496892T3 (es)
HK (1) HK1186671A1 (es)
IL (1) IL225668A (es)
IT (1) IT1402018B1 (es)
MX (1) MX342986B (es)
PL (1) PL2627345T3 (es)
PT (1) PT2627345E (es)
RU (1) RU2580643C2 (es)
SG (1) SG189345A1 (es)
SI (1) SI2627345T1 (es)
WO (1) WO2012049045A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6075526B2 (ja) * 2012-07-04 2017-02-08 アサヒビール株式会社 ビール又はビール様飲料及びその製造方法
PT2908834T (pt) * 2012-10-17 2017-10-19 Montero Gida Sanayi Ve Ticaret As Novas formulações compreendendo extratos de planta
CN104304548A (zh) * 2014-10-27 2015-01-28 陈国勇 一种预防感冒茶及其制备方法
EP3103464A1 (en) 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of disorders of the mouth, throat and respiratory tract
EP3103465A1 (en) 2015-06-10 2016-12-14 Raman Mehta Formulations for the treatment of mucosal lesions
CA2999764A1 (en) 2015-09-22 2017-03-30 Vitality Biopharma, Inc. Cannabinoid glycoside prodrugs and methods of synthesis
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
WO2018208875A1 (en) * 2017-05-09 2018-11-15 Vitality Biopharma, Inc. Antimicrobial compositions comprising cannabinoids and methods of using the same
CA3131585A1 (en) * 2019-03-29 2020-10-08 Jean-Luc Herbeaux Combined preparation comprising an anthocyanin composition and an antiviral agent
WO2020201055A1 (en) * 2019-03-29 2020-10-08 Evonik Operations Gmbh Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by pneumoviridae
US20220184163A1 (en) * 2019-03-29 2022-06-16 Evonik Operations Gmbh Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by paramyxoviridae
KR102232733B1 (ko) * 2019-04-16 2021-03-26 주식회사 파미니티 에키네시아 추출물을 포함하는 항바이러스용 조성물
IT201900024997A1 (it) * 2019-12-20 2021-06-20 Dymalife Res S R L Associazione per uso nel trattamento e/o prevenzione degli stati influenzali e delle affezioni delle alte vie respiratorie
IT202000018949A1 (it) 2020-08-03 2022-02-03 Arterra Bioscience S P A Estratto derivato da bucce di punica granatum per la prevenzione e il trattamento di infezioni virali

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106972B2 (ja) * 1987-04-24 1995-11-15 佐藤製薬株式会社 歯科口腔用薬剤
AU742780B2 (en) * 1998-01-30 2002-01-10 Rhinopharma As Herbal anti-viral agent
JP2000136141A (ja) * 1998-10-30 2000-05-16 Sumitomo Forestry Co Ltd 抗菌剤
US6241975B1 (en) * 1999-07-24 2001-06-05 Pacific Corporation Method for preparation of plant extract powder
JP2001122795A (ja) * 1999-10-27 2001-05-08 Nissui Pharm Co Ltd 感染性疾患予防・治療剤
IL143318A0 (en) * 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
CN1164299C (zh) * 2001-09-07 2004-09-01 张印昌 治疗急慢性炎症的中药制剂克炎口服液及制作方法
JP2003113013A (ja) * 2001-09-28 2003-04-18 Lion Corp 植物性抗菌防腐剤
JP4444593B2 (ja) * 2003-08-21 2010-03-31 日本メナード化粧品株式会社 抗菌剤
ITMI20032287A1 (it) 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
ITMI20042414A1 (it) 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
US20080057143A1 (en) 2006-06-01 2008-03-06 Mohammad Madjid Method of using composition comprising pomegranate extracts against influenza
CN101057953A (zh) * 2006-04-21 2007-10-24 陈祖辉 对付病毒感染疾患的多靶协同防治制剂
US20070275104A1 (en) * 2006-05-12 2007-11-29 Kornman Kenneth S Food Compositions and Methods of Treating Periodontal Disease
US7820207B2 (en) * 2007-03-15 2010-10-26 Omnica Gmbh Stabilized anthocyanin compositions
US20090035226A1 (en) * 2007-07-31 2009-02-05 Phenolics, Llc Use of cranberry extract enriched in total phenols and free, essentially free, or substantially free of sugars, acids, sulfur and other contaminants, for periodontal treatment
AU2009240294B2 (en) 2008-04-24 2014-04-10 Indena S.P.A. Compositions for the treatment and prevention of infections of the oral cavity
CA2724607A1 (en) * 2008-05-30 2009-12-31 Fairfield Clinical Trials, Llc Method and composition for skin inflammation and discoloration
RU2518738C2 (ru) * 2008-06-05 2014-06-10 Индена С.П.А. Композиции для лечения заболеваний верхних дыхательных путей и симптомокомплекса гриппа

Also Published As

Publication number Publication date
IL225668A (en) 2016-12-29
PT2627345E (pt) 2014-09-04
EP2627345A1 (en) 2013-08-21
SI2627345T1 (sl) 2014-10-30
JP6250397B2 (ja) 2017-12-20
AU2011315708A1 (en) 2013-04-18
WO2012049045A1 (en) 2012-04-19
AU2011315708B2 (en) 2014-03-20
SG189345A1 (en) 2013-05-31
HK1186671A1 (en) 2014-03-21
DK2627345T3 (da) 2014-09-01
US20130280355A1 (en) 2013-10-24
CN103189065B (zh) 2015-03-18
AR083366A1 (es) 2013-02-21
MX2013004008A (es) 2013-04-24
BR112013008771A2 (pt) 2021-04-20
JP2016155878A (ja) 2016-09-01
BR112013008771B1 (pt) 2022-02-22
IL225668A0 (en) 2013-06-27
JP2013539770A (ja) 2013-10-28
RU2013121576A (ru) 2014-11-20
CA2814312C (en) 2021-10-12
US9168276B2 (en) 2015-10-27
KR101870979B1 (ko) 2018-06-25
ITMI20101852A1 (it) 2012-04-12
IT1402018B1 (it) 2013-08-28
RU2580643C2 (ru) 2016-04-10
PL2627345T3 (pl) 2015-01-30
ES2496892T3 (es) 2014-09-22
CN103189065A (zh) 2013-07-03
KR20130142115A (ko) 2013-12-27
CA2814312A1 (en) 2012-04-19
EP2627345B1 (en) 2014-07-23

Similar Documents

Publication Publication Date Title
MX342986B (es) Formulaciones para el tratamiento de las afecciones de las vias aereas superiores.
MY158438A (en) Antibodies against human angiopoietin 2
UA109949C2 (uk) Композиція і лікарський засіб, які містять ідуронат-2-сульфатазу, і спосіб їх отримання
EP4324479A3 (en) Methods for treating or preventing asthma by administering an il-4r antagonist
IN2012DN06720A (es)
WO2011141685A3 (fr) Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants
GB2488500B (en) Substances for use as anti-depressants or as a learning motivation improver
MX2012007806A (es) Composiciones farmaceuticas para administracion oral de peptidos de insulina.
HN2006009000A (es) Formas farmaceuticas con propiedades farmacocineticas mejoradas
MY161595A (en) Oral care compositions
TN2012000566A1 (en) Dry powder formulation comprising an antimuscarinic drug
AP2014008162A0 (en) Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
IL222419A0 (en) Novel formulations of active ingredient (s) of plant origin or synthetic analogues thereof or of extract (s) of plant origin containing same, and of lecitihin
WO2011076840A3 (en) Aerosol formulation for copd
IL209714A0 (en) Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes
GB2498677A (en) Extracts of cynanchum SP.and active ingredients contained therein in use of arthritis treatment
MX2014006201A (es) Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
NZ630125A (en) Herbal composition for the treatment of metabolic disorders
BR112015023872A2 (pt) composição compreendendo arabinogalactano e poliofenóis de árvores de lariço
WO2010143140A3 (en) Pharmaceutical compositions comprising extracts of sarcopoterium spinosum, components thereof, and uses thereof
WO2012017022A3 (fr) Composition pharmaceutique contenant un extrait de serenoa repens
TR200907915A2 (tr) Kuru toz formunda farmasötik bileşim.
UA36724U (ru) Состав сухой микстуры от кашля

Legal Events

Date Code Title Description
FG Grant or registration